drugset / Trial / NCT01538394
Clinical Trial to Evaluate the Efficacy of Smoking Cessation
RandomizedParallel-groupDouble-blind
Summary
The purpose of this study is to assess the efficacy of smoking cessation by using varenicline as monotherapy (VRN + placebo patches) or combined therapy (VRN + nicotine patches).
Timeline
- Start
- 2012-01
- Primary completion
- 2013-06
- Completion
- 2013-06
Publications
- Livingstone-Banks J, Fanshawe TR, Thomas KH, Theodoulou A, Hajizadeh A, Hartman L, Lindson N. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2023 May 5;5(5):CD006103. doi: 10.1002/14651858.CD006103.pub8.
- Ramon JM, Morchon S, Baena A, Masuet-Aumatell C. Combining varenicline and nicotine patches: a randomized controlled trial study in smoking cessation. BMC Med. 2014 Oct 8;12:172. doi: 10.1186/s12916-014-0172-8.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nicotine | Unknown | — | Other |
| Subject | Varenicline | Small molecule | 1 mg | — |
Indications
No indication recorded.